Quidel
QuidelOrtho Preliminary Q4 Earnings Beat Estimates
The firm expects its Q4 non-COVID core revenues to increase approximately 18 percent and full-year core revenues to increase approximately 11 percent.
QuidelOrtho, Access Bio, iHealth, Orasure Nab DoD Contract for COVID-19 Antigen Tests
The companies will share the proceeds of the contract, worth up to $803 million, and provide the tests to HHS.
QuidelOrtho, Runda Medical to Form Immunodiagnostic Joint Venture in China
The joint venture will develop and manufacture assays in China for QuidelOrtho's Vitros immunodiagnostic platform.
The firm also said it will shift its near-term regulatory and commercial strategy for its Savanna molecular diagnostic instrument.
360Dx Top 30 Rises 2 Percent After Months of Decline
Of the 30 companies in the index, 22 saw their stock prices rise, while eight firms saw their share prices decrease.
Oct 12, 2022
QuidelOrtho Reports Preliminary Q3 Revenues
Sep 7, 2022
Aug 18, 2022
QuidelOrtho Board Authorizes $300M Share Repurchase
Aug 5, 2022
QuidelOrtho Q2 Revenues Rise 34 Percent
Apr 8, 2022
Quidel Expects up to $1B in Q1 Revenues
Feb 17, 2022
Quidel Q4 Revenues Drop 21 Percent, Beat Estimates
Jan 10, 2022
Nov 30, 2021